Global Life Science Ventures — Investing in the life sciences

Global Life Science Ventures (GLSV) is a leading, independent venture capital fund focusing exclusively on the life sciences. GLSV is dedicated to supporting early-stage groups, originating from universities, scientific institutions or industry. The fund may also invest in selected later stage companies, including buy-outs. For this purpose, GLSV provides finance, advice and access to expertise and networks. The group currently advises and manages funds totalling more than € 200 million. With offices in Germany and Switzerland, GLSV acts as one team with a global perspective.

Text size

GLSV news archive

01.02.2013 Global Life Science Ventures: 2012 Review more...

30.01.2012 Global Life Science Ventures: 2011 Review more...

24.01.2011 Global Life Science Ventures: 2010 Review more...

14.01.2010 Global Life Science Ventures: 2009 Review more...

13.02.2009 Global Life Science Ventures: 2008 highlights more...

22.04.2008 GLSV receives 2007 Dyodelta European Life Science Innovation Award "Investor of the Year Award" more...

14.04.2008 April 2008 Teil 20 der Serie: Köpfe der deutschsprachigen Private Equity-Szene, Hanns-Peter Wiese, Venture Capial Magazin 4/2008 more...

17.01.2008 GLSV leads investment in Action Pharma A/S more...

06.12.2007 GLSV invests in Pelikan Technologies more...

02.10.2007 Biotech Investment Barometer Reveals Continued Confidence in Sector
more...

11.05.2007 NeurogesX Launches IPO on NASDAQ more...

29.03.2007 GLSV co-leads Series E investment in Coapt Systems more...

20.12.2006 "10 years' investing in the life sciences" more...

30.10.2006 GLSV Invests in Intelligent Medical Implants - Visual Prosthesis for the Blind more...

03.10.2006 GLSV Biotech Investment Barometer Reveals Continued Optimism
more...

16.03.2006 GLSV invests in Santaris Pharma A/S more...

31.01.2006 GLSV receives European Venture Capital Journal (EVCJ) award for "Venture Realisation of the Year" in the Life Sciences category. GLSV was additionally nominated as "VC House of the Year" in the Life Sciences.

31.01.2006 GLSV co-finances Nabriva GmbH, an antibiotic research company spun off from Sandoz more...

10.11.2005 CombinatorX lists on NASDAQ more...

04.10.2005 Investment Survey Reveals Increased Confidence in Biotechnology Sector more...

19.09.2005 GLSV Co-leads Investment in Neuraxo Biotec more...

11.08.2005 Coley Pharmaceutical Group lists on NASDAQ more...

19.07.2005 Roche signs agreement to acquire GlycArt Biotechnology AG, a GLSV portfolio company more...

16.03.2005 Global Life Science and Atlas Venture co-lead investment into Fibrex Medical Inc. more...

10.03.2005 Intercell listed on the Vienna Stock Exchange more...

15.02.2005 Global Life Science Ventures: 2004 highlights more...

15.12.2004 Cyberkinetics Inc. completes merger and public listing more...

12.10.2004 Holger Reithinger joins the investment team of Global Life Science Ventures from the 3i Group more...

01.10.2004 Atlas Venture and Global Life Science Ventures invest in Nitec Pharma AG more...

13.09.2004 GLSV makes further investment into Xantos Biomedicine AG more...

13.08.2004 MediGene Strengthens Drug Pipline by Acquiring Anti-Cancer Drugs and Tech-nology of Munich Biotech AG more...

17.06.2004 Dr. Bert S.J. van Toor joins the investment team of Global Life Science Ventures more...

27.04.2004 Global Life Science Ventures: 2003 highlights more...

06.04.2004 Global Life Science Ventures announces Memory Pharmaceuticals Corp. went public through a listing on the NASDAQ more...

30.03.2004 Global Life Science Ventures announces investment into Agendia BV more...

08.03.2004 Global Life Science Ventures announces investment into CareX S.A. more...

25.02.2004 Global Life Science Ventures announces lead investment into NeurogesX more...

26.11.2003 Global Life Science Ventures invests into Glycart Biotechnology AG more...

30.10.2003 Global Life Science Ventures invests into Converge Medical more...

24.09.2003 Global Life Science Ventures makes further investments into the Coley Pharmaceutical Group. more...

17.07.2003 Global Life Science Ventures announces lead investment into Intercell AG more...

08.07.2003 Global Life Science Ventures invests into Cyberkinetics, Inc. more...

< back